Monoclonal Antibodies Product Market - Global Outlook and Forecast 2022-2028

January 2022 | 69 pages | ID: M34DB984A12CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Monoclonal Antibodies Product in Global, including the following market information:

Global Monoclonal Antibodies Product Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Monoclonal Antibodies Product market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Monoclonal Antibodies Product include AbbVie, Roche, Johnson & Johnson, Amgen, Merck, Pfizer, Novartis, Eli Lilly and GlaxoSmithKline. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Monoclonal Antibodies Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Monoclonal Antibodies Product Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Monoclonal Antibodies Product Market Segment Percentages, by Type, 2021 (%)

• Cancer
• Autoimmune Diseases
• Infection
• Hematological Diseases
• Others

Global Monoclonal Antibodies Product Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Monoclonal Antibodies Product Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Academic Institutes
• Clinics
• Diagnostic Laboratories

Global Monoclonal Antibodies Product Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Monoclonal Antibodies Product Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Monoclonal Antibodies Product revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Monoclonal Antibodies Product revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Roche
• Johnson & Johnson
• Amgen
• Merck
• Pfizer
• Novartis
• Eli Lilly
• GlaxoSmithKline

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Monoclonal Antibodies Product Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Monoclonal Antibodies Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MONOCLONAL ANTIBODIES PRODUCT OVERALL MARKET SIZE

2.1 Global Monoclonal Antibodies Product Market Size: 2021 VS 2028
2.2 Global Monoclonal Antibodies Product Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Monoclonal Antibodies Product Players in Global Market
3.2 Top Global Monoclonal Antibodies Product Companies Ranked by Revenue
3.3 Global Monoclonal Antibodies Product Revenue by Companies
3.4 Top 3 and Top 5 Monoclonal Antibodies Product Companies in Global Market, by Revenue in 2021
3.5 Global Companies Monoclonal Antibodies Product Product Type
3.6 Tier 1, Tier 2 and Tier 3 Monoclonal Antibodies Product Players in Global Market
  3.6.1 List of Global Tier 1 Monoclonal Antibodies Product Companies
  3.6.2 List of Global Tier 2 and Tier 3 Monoclonal Antibodies Product Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Monoclonal Antibodies Product Market Size Markets, 2021 & 2028
  4.1.2 Cancer
  4.1.3 Autoimmune Diseases
  4.1.4 Infection
  4.1.5 Hematological Diseases
  4.1.6 Others
4.2 By Type - Global Monoclonal Antibodies Product Revenue & Forecasts
  4.2.1 By Type - Global Monoclonal Antibodies Product Revenue, 2017-2022
  4.2.2 By Type - Global Monoclonal Antibodies Product Revenue, 2023-2028
  4.2.3 By Type - Global Monoclonal Antibodies Product Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Monoclonal Antibodies Product Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Academic Institutes
  5.1.4 Clinics
  5.1.5 Diagnostic Laboratories
5.2 By Application - Global Monoclonal Antibodies Product Revenue & Forecasts
  5.2.1 By Application - Global Monoclonal Antibodies Product Revenue, 2017-2022
  5.2.2 By Application - Global Monoclonal Antibodies Product Revenue, 2023-2028
  5.2.3 By Application - Global Monoclonal Antibodies Product Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Monoclonal Antibodies Product Market Size, 2021 & 2028
6.2 By Region - Global Monoclonal Antibodies Product Revenue & Forecasts
  6.2.1 By Region - Global Monoclonal Antibodies Product Revenue, 2017-2022
  6.2.2 By Region - Global Monoclonal Antibodies Product Revenue, 2023-2028
  6.2.3 By Region - Global Monoclonal Antibodies Product Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Monoclonal Antibodies Product Revenue, 2017-2028
  6.3.2 US Monoclonal Antibodies Product Market Size, 2017-2028
  6.3.3 Canada Monoclonal Antibodies Product Market Size, 2017-2028
  6.3.4 Mexico Monoclonal Antibodies Product Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Monoclonal Antibodies Product Revenue, 2017-2028
  6.4.2 Germany Monoclonal Antibodies Product Market Size, 2017-2028
  6.4.3 France Monoclonal Antibodies Product Market Size, 2017-2028
  6.4.4 U.K. Monoclonal Antibodies Product Market Size, 2017-2028
  6.4.5 Italy Monoclonal Antibodies Product Market Size, 2017-2028
  6.4.6 Russia Monoclonal Antibodies Product Market Size, 2017-2028
  6.4.7 Nordic Countries Monoclonal Antibodies Product Market Size, 2017-2028
  6.4.8 Benelux Monoclonal Antibodies Product Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Monoclonal Antibodies Product Revenue, 2017-2028
  6.5.2 China Monoclonal Antibodies Product Market Size, 2017-2028
  6.5.3 Japan Monoclonal Antibodies Product Market Size, 2017-2028
  6.5.4 South Korea Monoclonal Antibodies Product Market Size, 2017-2028
  6.5.5 Southeast Asia Monoclonal Antibodies Product Market Size, 2017-2028
  6.5.6 India Monoclonal Antibodies Product Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Monoclonal Antibodies Product Revenue, 2017-2028
  6.6.2 Brazil Monoclonal Antibodies Product Market Size, 2017-2028
  6.6.3 Argentina Monoclonal Antibodies Product Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Monoclonal Antibodies Product Revenue, 2017-2028
  6.7.2 Turkey Monoclonal Antibodies Product Market Size, 2017-2028
  6.7.3 Israel Monoclonal Antibodies Product Market Size, 2017-2028
  6.7.4 Saudi Arabia Monoclonal Antibodies Product Market Size, 2017-2028
  6.7.5 UAE Monoclonal Antibodies Product Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Monoclonal Antibodies Product Major Product Offerings
  7.1.4 AbbVie Monoclonal Antibodies Product Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Monoclonal Antibodies Product Major Product Offerings
  7.2.4 Roche Monoclonal Antibodies Product Revenue in Global Market (2017-2022)
  7.2.5 Roche Key News
7.3 Johnson & Johnson
  7.3.1 Johnson & Johnson Corporate Summary
  7.3.2 Johnson & Johnson Business Overview
  7.3.3 Johnson & Johnson Monoclonal Antibodies Product Major Product Offerings
  7.3.4 Johnson & Johnson Monoclonal Antibodies Product Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Key News
7.4 Amgen
  7.4.1 Amgen Corporate Summary
  7.4.2 Amgen Business Overview
  7.4.3 Amgen Monoclonal Antibodies Product Major Product Offerings
  7.4.4 Amgen Monoclonal Antibodies Product Revenue in Global Market (2017-2022)
  7.4.5 Amgen Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Monoclonal Antibodies Product Major Product Offerings
  7.5.4 Merck Monoclonal Antibodies Product Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Monoclonal Antibodies Product Major Product Offerings
  7.6.4 Pfizer Monoclonal Antibodies Product Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Monoclonal Antibodies Product Major Product Offerings
  7.7.4 Novartis Monoclonal Antibodies Product Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News
7.8 Eli Lilly
  7.8.1 Eli Lilly Corporate Summary
  7.8.2 Eli Lilly Business Overview
  7.8.3 Eli Lilly Monoclonal Antibodies Product Major Product Offerings
  7.8.4 Eli Lilly Monoclonal Antibodies Product Revenue in Global Market (2017-2022)
  7.8.5 Eli Lilly Key News
7.9 GlaxoSmithKline
  7.9.1 GlaxoSmithKline Corporate Summary
  7.9.2 GlaxoSmithKline Business Overview
  7.9.3 GlaxoSmithKline Monoclonal Antibodies Product Major Product Offerings
  7.9.4 GlaxoSmithKline Monoclonal Antibodies Product Revenue in Global Market (2017-2022)
  7.9.5 GlaxoSmithKline Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Monoclonal Antibodies Product Market Opportunities & Trends in Global Market
Table 2. Monoclonal Antibodies Product Market Drivers in Global Market
Table 3. Monoclonal Antibodies Product Market Restraints in Global Market
Table 4. Key Players of Monoclonal Antibodies Product in Global Market
Table 5. Top Monoclonal Antibodies Product Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Monoclonal Antibodies Product Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Monoclonal Antibodies Product Revenue Share by Companies, 2017-2022
Table 8. Global Companies Monoclonal Antibodies Product Product Type
Table 9. List of Global Tier 1 Monoclonal Antibodies Product Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monoclonal Antibodies Product Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Monoclonal Antibodies Product Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Monoclonal Antibodies Product Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Monoclonal Antibodies Product Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Monoclonal Antibodies Product Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Monoclonal Antibodies Product Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Monoclonal Antibodies Product Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Monoclonal Antibodies Product Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Monoclonal Antibodies Product Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Monoclonal Antibodies Product Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Monoclonal Antibodies Product Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Monoclonal Antibodies Product Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Monoclonal Antibodies Product Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Monoclonal Antibodies Product Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Monoclonal Antibodies Product Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Monoclonal Antibodies Product Product Offerings
Table 32. AbbVie Monoclonal Antibodies Product Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Monoclonal Antibodies Product Product Offerings
Table 35. Roche Monoclonal Antibodies Product Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Monoclonal Antibodies Product Product Offerings
Table 38. Johnson & Johnson Monoclonal Antibodies Product Revenue (US$, Mn), (2017-2022)
Table 39. Amgen Corporate Summary
Table 40. Amgen Monoclonal Antibodies Product Product Offerings
Table 41. Amgen Monoclonal Antibodies Product Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Monoclonal Antibodies Product Product Offerings
Table 44. Merck Monoclonal Antibodies Product Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Monoclonal Antibodies Product Product Offerings
Table 47. Pfizer Monoclonal Antibodies Product Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Monoclonal Antibodies Product Product Offerings
Table 50. Novartis Monoclonal Antibodies Product Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly Corporate Summary
Table 52. Eli Lilly Monoclonal Antibodies Product Product Offerings
Table 53. Eli Lilly Monoclonal Antibodies Product Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline Corporate Summary
Table 55. GlaxoSmithKline Monoclonal Antibodies Product Product Offerings
Table 56. GlaxoSmithKline Monoclonal Antibodies Product Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Monoclonal Antibodies Product Segment by Type in 2021
Figure 2. Monoclonal Antibodies Product Segment by Application in 2021
Figure 3. Global Monoclonal Antibodies Product Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Monoclonal Antibodies Product Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Monoclonal Antibodies Product Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Monoclonal Antibodies Product Revenue in 2021
Figure 8. By Type - Global Monoclonal Antibodies Product Revenue Market Share, 2017-2028
Figure 9. By Application - Global Monoclonal Antibodies Product Revenue Market Share, 2017-2028
Figure 10. By Region - Global Monoclonal Antibodies Product Revenue Market Share, 2017-2028
Figure 11. By Country - North America Monoclonal Antibodies Product Revenue Market Share, 2017-2028
Figure 12. US Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Monoclonal Antibodies Product Revenue Market Share, 2017-2028
Figure 16. Germany Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 17. France Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Monoclonal Antibodies Product Revenue Market Share, 2017-2028
Figure 24. China Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 28. India Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Monoclonal Antibodies Product Revenue Market Share, 2017-2028
Figure 30. Brazil Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Monoclonal Antibodies Product Revenue Market Share, 2017-2028
Figure 33. Turkey Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Monoclonal Antibodies Product Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Monoclonal Antibodies Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Monoclonal Antibodies Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Monoclonal Antibodies Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amgen Monoclonal Antibodies Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Monoclonal Antibodies Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Monoclonal Antibodies Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Monoclonal Antibodies Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly Monoclonal Antibodies Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline Monoclonal Antibodies Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)